Emergent HIV drug resistance in non-inferiority trials
Lancet HIV
.
2023 Oct;10(10):e632-e634.
doi: 10.1016/S2352-3018(23)00203-5.
Epub 2023 Sep 12.
Authors
Diego Ripamonti
1
,
Maurizio Zazzi
2
Affiliations
1
Infectious Diseases Unit, ASST Papa Giovanni XXIII Hospital, Bergamo 24127, Italy. Electronic address: diego.ripamonti@hotmail.com.
2
Department of Medical Biotechnology, University of Siena, Siena, Italy.
PMID:
37714175
DOI:
10.1016/S2352-3018(23)00203-5
No abstract available
Publication types
Editorial
MeSH terms
Emtricitabine
HIV Infections* / drug therapy
Humans
Tenofovir
Treatment Outcome
Substances
Tenofovir
Emtricitabine